Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Study Number

933720

Phase

Age Group

Adult

Principal Investigator

Purpose

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer

Check your eligibility for this trial

Check now

Full Title

A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Metastatic Non-Small-Cell Lung Cancer

ClinicalTrials.Gov ID

NCT04614103

Get more information and eligibility criteria for this trial at ClinicalTrials.gov

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.